James Macfarlane
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 6
-
- Cystic Fibrosis Research Advances 4
- Co-authors
- Anthony De Soyza (4 shared papers)Graham Burns (2 shared papers)Richard Quinton (2 shared papers)Christopher S. Boot (2 shared papers)Katy L. M. Hester (2 shared papers)Adrian R. Martineau (2 shared papers)Grigorios Panagiotou (2 shared papers)Su Ann Tee (2 shared papers)
- Journals
- The Lancet (6 papers)Thorax (3 papers)Clinical Endocrinology (2 papers)Respiratory Medicine (1 paper)Journal of Inflammation (1 paper)
- Partner nations
- United KingdomAustraliaVietnam
In The Last Decade
James Macfarlane
21 papers receiving 2.1k citations
James Macfarlane's Hit Papers
Peers
Comparison fields: 5 of 95
- Infectious Diseases 1.3k
- Applied Microbiology and Biotechnology 39
- Pathology and Forensic Medicine 224
- Internal Medicine 27
- Critical Care and Intensive Care Medicine 35
Countries citing papers authored by James Macfarlane
This map shows the geographic impact of James Macfarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Macfarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Macfarlane more than expected).
Fields of papers citing papers by James Macfarlane
This network shows the impact of papers produced by James Macfarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Macfarlane. The network helps show where James Macfarlane may publish in the future.
Co-authors
The 25 scholars most cited alongside James Macfarlane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 5 | 2021 | 213 | |
| 6 | 2020 | 166 | |
| 7 | 2014 | 121 | |
| 8 | 2001 | 84 | |
| 9 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 10 | 2014 | 65 | |
| 11 | 2018 | 56 | |
| 12 | 2015 | 27 | |
| 13 | 2013 | 17 | |
| 14 | 2002 | 16 | |
| 15 | 2012 | 10 | |
| 16 | 2020 | 10 | |
| 17 | 2008 | 8 | |
| 18 | 2005 | 7 | |
| 19 | 2020 | 7 | |
| 20 | 2010 | 6 |
About James Macfarlane
James Macfarlane is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Psychiatry and Mental health and Immunology, having authored 21 papers that have together received 2.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Cystic Fibrosis Research Advances (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers), Vitamin D Research Studies (2 papers), Systemic Sclerosis and Related Diseases (1 paper), Smoking Behavior and Cessation (1 paper) and Sepsis Diagnosis and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (1.3k citations), Applied Microbiology and Biotechnology (39 citations), Pathology and Forensic Medicine (224 citations), Internal Medicine (27 citations) and Critical Care and Intensive Care Medicine (35 citations). James Macfarlane has collaborated with scholars based in United Kingdom, Australia and Vietnam. Frequent co-authors include Anthony De Soyza, Graham Burns, Richard Quinton, Christopher S. Boot, Katy L. M. Hester, Adrian R. Martineau, Grigorios Panagiotou, Su Ann Tee, Malcolm Anders Smith and Hannah R. Jary. Their work appears in journals such as The Lancet, Thorax, Clinical Endocrinology, Respiratory Medicine and Journal of Inflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.